Taiwan Liposome Co Ltd TLC:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/04/21 EST
4.90quote price arrow down-0.44 (-8.24%)
Volume
20,138
52 week range
2.48 - 12.65

...

Loading . . .

KEY STATS

  • Open5.39
  • Day High5.39
  • Day Low4.86
  • Prev Close4.90
  • 52 Week High12.65
  • 52 Week High Date07/15/20
  • 52 Week Low2.48
  • 52 Week Low Date03/16/20
  • Market Cap224.69M
  • Shares Out42.08M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta1
  • 1 Year % Change4.06

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/29/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Taiwan Liposome Co Ltd News

There is no recent news for this security.

Latest TLC News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Taiwan Liposome Company, Ltd. is a Taiwan-based company principally engaged in the research and development and commercialization of lipid drug delivery systems. The Company is engaged in the development of special generic drugs, new formulas and new drugs using patents. The Company's therapeutic areas include pain management, eye diseases and cancer. Its anticancer medicine product named Lipo-Dox has been distributed in domestic and Asian markets.
Jilong Hong
Chairman
Address
2F
No.3, Yuanqu Street, Nangang District
Taipei
115
Taiwan